Cancers (Dec 2023)

Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 Patients

  • Stine Møller,
  • Seppo W. Langer,
  • Cecilie Slott,
  • Jesper Krogh,
  • Carsten Palnæs Hansen,
  • Andreas Kjaer,
  • Pernille Holmager,
  • Marianne Klose,
  • Rajendra Singh Garbyal,
  • Ulrich Knigge,
  • Mikkel Andreassen

DOI
https://doi.org/10.3390/cancers16010100
Journal volume & issue
Vol. 16, no. 1
p. 100

Abstract

Read online

Introduction: The prognosis and impact of different prognostic factors in pancreatic neuroendocrine neoplasms (pNEN) remain controversial. Aim: To investigate prognostic factors for recurrence-free survival and disease-specific survival in patients with pNEN, divided into three groups: patients undergoing surveillance (tumor size p p = 0.02), and location in the pancreatic head (p p = 0.029), plasma chromogranin A (p = 0.014), and proliferation, expressed by grade (p = 0.001) and Ki-67 index (p < 0.001), were risk factors. Conclusion: Growth in pNET < 2 cm requiring surgery was observed in 1/51. Tumor size, Ki-67 index, and location in the head were prognostic factors for disease recurrence, while age, plasma chromogranin A, and proliferation predicted mortality in patients with unresectable disease or residual tumors after resection.

Keywords